-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE REPORTS SUCCESSFUL ONGOING TREATMENT OF PARTICIPANTS AT US SITES IN ITS FDA-APPROVED CMND-100 PHASE I/IIA CLINICAL TRIAL FOR ALCOHOL USE DISORDER

Reuters·03/19/2026 12:45:00

Please log in to view news